Acute kidney failure in patients admitted due to COVID-19
Author(s) -
Blanca Tarragón,
María Valdenebro,
María Luisa Serrano Salazar,
Alba Maroto,
M. Rosario Llópez-Carratalá,
António Ramos,
Esther Rubio,
Ana Huerta,
María Marqués,
José Pórtoles
Publication year - 2021
Publication title -
nefrología (english edition)
Language(s) - English
Resource type - Journals
ISSN - 2013-2514
DOI - 10.1016/j.nefroe.2021.02.006
Subject(s) - medicine , acute kidney injury , context (archaeology) , nephrology , ards , renal replacement therapy , pneumonia , sepsis , acute tubular necrosis , kidney disease , intensive care medicine , kidney , lung , paleontology , biology
In December 2019, a coronavirus 2019 (COVID-19) outbreak, caused by SARS-CoV-2, took place in Wuhan and was declared a global pandemic in March 2020 by the World Health Organization (WHO). It is a prominently respiratory infection, with potential cardiological, hematological, gastrointestinal and renal complications. Acute kidney injury (AKI) is found in 0.5%-25% of hospitalized COVID-19 patients and constitutes a negative prognostic factor. Renal damage mechanisms are not completely clear. We report the clinical evolution of hospitalized COVID-19 patients who presented with AKI requiring attention from the Nephrology team in a tertiary hospital in Madrid, Spain.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom